Intellectual Property Law Blog

MAY 2, 2023

The AI Bill of Rights is a voluntary, non-binding framework, but federal agencies likely will consider it as they craft guidance and requirements regarding the development and use of artificial intelligence. Like the AI Bill of Rights, compliance with this framework is voluntary but the purpose of the AI RMF 1.0

Government 237

Government Business Licensing Copyright 237

LexBlog IP

FEBRUARY 7, 2024

Another development was the publication of the G7 voluntary code of conduct for developers of advanced AI systems. [10] 4] Globally, countries are at varying stages in enacting rules governing AI, signalling a range of approaches to the technology’s regulation across jurisdictions. [5]

Publishing 52

Publishing Government Litigation Inventor 52

Patently-O

FEBRUARY 24, 2022

The Kessler Doctrine : If you want to really dig into this case, please read my article on the topic that I wrote for an Akron Law review IP symposium issue. In its petition, PersonalWeb argues that Kessler should not be seen as a freestanding doctrine and should not apply in situations involving voluntary dismissal.

Patent Law 95

Patent Law Law Patent Litigation 95

LexBlog IP

MAY 2, 2023

The AI Bill of Rights is a voluntary, non-binding framework, but federal agencies likely will consider it as they craft guidance and requirements regarding the development and use of artificial intelligence. Like the AI Bill of Rights, compliance with this framework is voluntary but the purpose of the AI RMF 1.0 ” AI RMF 1.0

Government 52

Government Business Copyright Licensing 52

SpicyIP

JULY 11, 2021

Topical Highlight. Recounting the facts of the case, he argues that disclosure of thesis which is mandated by an Ordinance is not discretionary, and that since it is a mandatory suo motu disclosure under Section 4, it cannot be fit within the exceptions available under Section 8.

Moral Rights 105

Moral Rights Journalism Licensing IP 105

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

The letter discusses the BPCIA and the Hatch-Waxman Act frameworks (for small molecule drugs) and sets forth several topics for USPTO’s consideration and further discussion: engagement between FDA and USPTO to increase efficiencies, possible misuse of the patent system (e.g., The court dismissed the case without prejudice on November 5, 2021.

Litigation 52

Litigation Settlement Patent Marketing 52

Technology & Marketing Law Blog

NOVEMBER 8, 2021

Yesterday I presented at UC Hastings’ Pound Civil Justice Institute on my forthcoming paper that questions the constitutionality of mandatory disclosure obligations imposed on Internet services. Similarly, restyling mandatory disclosure laws as standard UDAP/consumer protection doesn’t address the underlying entanglement problems.

Government 118

Government Publishing Privacy Reporting 118